Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Physiology and Pathophysiology
SJR: 0.116

ISSN Imprimir: 2155-014X
ISSN En Línea: 2155-0158

Archives: Volume 1, 2010 to Volume 9, 2018

International Journal of Physiology and Pathophysiology

DOI: 10.1615/IntJPhysPathophys.v6.i1.70
pages 61-68

Serum Levels of Endothelial Monocyte-Activating Polypeptide-II in type 2 Diabetes Mellitus

Liliya A. Mogylnytska
Khmelnytsky Regional Hospital, Khmelnytsky, Ukraine

SINOPSIS

Endothelial dysfunction is implicated in the pathogenesis of macrovascular complications of diabetes and atherosclerosis. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional polypeptide with proinflammatory and antiangiogenic activity. The aim of the study was to investigate the serum level of EMAP-II in obese and non-obese patients with type 2 diabetes mellitus. We have found an increase in the serum level of EMAP-II in obese diabetic patients compared to obese subjects without diabetes, and in non-obese diabetic patients compared to control subjects. Moreover, a significant elevation of the serum EMAP-II in obese patients without diabetes compared to control subjects was observed. In obese and non-obese patients with diabetes mellitus, the serum levels of EMAP-II correlate significantly with HbAc1, blood glucose, body mass index, as well as with total cholesterol, LDL, HDL, and triglycerides. The revealed elevation of the serum level of EMAP-II reflects endothelial dysfunction in patients with type 2 diabetes mellitus. Hyperglycemia, dyslipidemia and obesity appear to be significant factors to contribute to elevation of EMAP-II level.


Articles with similar content:

Effects of Tobacco on Biochemical Parameters in Healthy and Type 2 Diabetic Subjects
Journal of Environmental Pathology, Toxicology and Oncology, Vol.39, 2020, issue 1
Saima Wajid, Swatantra Kumar Jain, Shridhar Dwivedi, Bhumika Upadhyay
Understanding the Skeletal Pathology of Type 1 and 2 Diabetes Mellitus
Critical Reviews™ in Eukaryotic Gene Expression, Vol.21, 2011, issue 2
Sandi Raehtz, Laura McCabe, Jing Zhang
Endothelial Monocyte Activating Peptide II: Serum Levels in Type 1 Diabetes Mellitus
International Journal of Physiology and Pathophysiology, Vol.8, 2017, issue 1
Liliya A. Mogylnytska, Olesya E. Mogylnytska
Epigenetics of Arterial Hypertension
International Journal of Physiology and Pathophysiology, Vol.9, 2018, issue 2
Viktoriia S. Potaskalova, Anatoliy P. Burlaka, Mykola V. Khaitovych
Mechanisms Behind the Anti-inflammatory Actions of Insulin
Critical Reviews™ in Immunology, Vol.31, 2011, issue 4
Morley D. Hollenberg, Eric Hyun, Rithwik Ramachandran, Nathalie Vergnolle